Mobile technology to come in handy for Covid-19 vaccination drive, says PM Modi at IMC 2020 | Mint
Active Stocks
Fri Feb 23 2024 15:58:13
  1. Tata Steel share price
  2. 145.50 -0.24%
  1. State Bank Of India share price
  2. 759.40 -0.86%
  1. HDFC Bank share price
  2. 1,420.90 0.08%
  1. NTPC share price
  2. 337.70 -0.54%
  1. ITC share price
  2. 411.60 -0.65%
Business News/ News / India/  Mobile technology to come in handy for Covid-19 vaccination drive, says PM Modi at IMC 2020
BackBack

Mobile technology to come in handy for Covid-19 vaccination drive, says PM Modi at IMC 2020

PM Modi today said the mobile technology will be used for mass inoculation against the Covid-19 pandemic
  • Prime Minister Narendra Modi was delivering the inaugural address at the virtual India Mobile Congress (IMC) 2020 today
  • Prime Minister Narendra Modi.Premium
    Prime Minister Narendra Modi.

    New Delhi: With the chances of a coronavirus vaccine being available soon increasing, Prime Minister Narendra Modi today said the mobile technology will be used for mass inoculation against the pandemic.

    Speaking at the India Mobile Congress, he said. "It is also with the help of mobile technology that we will embark on one of the world's largest Covid-19 vaccination drive," he said.

    He did not provide details.

    Prime Minister Narendra Modi was delivering the inaugural address at the virtual India Mobile Congress (IMC) 2020 today.

    Also read: Why farm politics doesn't win elections in India

    On Monday, PM Modi had said that the country will not have to wait too long for the coronavirus vaccine while inaugurating the construction of the Agra Metro project via video conferencing. Before ending his speech, the prime minister said, "One thing, which I will definitely remind you is that the wait for a vaccine is on but in the past few days, I have met scientists, and feel that the country will not have to wait too long for it."

    Three leading coronavirus vaccine developers have applied for emergency use authorization in India

    Pfizer Inc, Serum Institute of India and Bharat Biotech have applied for emergency use authorization in India. While Pfizer India has applied to drug regulator for permission to import its experimental mRNA vaccine for sale and distribution without the requirement for local clinical trials, Serum Institute of India Ltd, AstraZeneca's India vaccine partner, has applied for emergency use authorisation using data from Phase-III trials that were conducted locally, as well as in Brazil and the UK. Hyderabad-based Bharat Biotech has sought nod Covaxin which is being indigenously developed in collaboration with the Indian Council of Medical Research (ICMR).


    Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

    Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Check all the latest action on Budget 2024 here. Download The Mint News App to get Daily Market Updates.
    More Less
    Published: 08 Dec 2020, 11:53 AM IST
    Next Story footLogo
    Recommended For You
    Switch to the Mint app for fast and personalized news - Get App